Drug
Vestronidase alfa clinical trials
Also written UX003, Mepsevii ™ and recombinant human beta-glucuronidase.
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses vestronidase alfa is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)CompletedPhase 3Ultragenyx Pharmaceutical IncNCT02432144Written as UX003
- A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)CompletedPhase 3Ultragenyx Pharmaceutical IncNCT02230566Written as UX003
- Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of AgeCompletedPhase 2Ultragenyx Pharmaceutical IncNCT02418455Written as UX003
- An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)CompletedPhase 1/2Ultragenyx Pharmaceutical IncNCT01856218Written as UX003
Codes
What other systems call vestronidase alfa · ClinicalTrials.gg INT001183
- MeSH (NLM) C000654126vestronidase alfaConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 7XZ4062R17VESTRONIDASE ALFAConfirmed FDA, NLM
- RxNorm 1989819One source FDA
- NCI Thesaurus C152871Vestronidase AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000654126 | vestronidase alfa | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 7XZ4062R17 | VESTRONIDASE ALFA | Confirmed FDA, NLM |
| RxNorm | 1989819 | — | One source FDA |
| NCI Thesaurus | C152871 | Vestronidase Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.